Data for NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? in human (Study ST000255)
(Analysis AN000403)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 |
|---|---|---|
| 10-Nitrolinoleate | NA | NA |
| 10-Nitrooleate | NA | NA |
| 11_12-DiHETrE | 0.8933 | 1.1067 |
| 11(12)-EpETE | NA | NA |
| 11(12)-EpETrE | NA | NA |
| 11-HETE | 0.7677 | 1.2323 |
| 12_13-DiHODE | NA | NA |
| 12_13-DiHOME (Area Ratio%) | 0.7165 | 1.2835 |
| 12(13)-Ep-9-KODE | 0.4962 | 1.5038 |
| 12(13)-EpODE | NA | NA |
| 12(13)-EpOME | 0.7628 | 1.2372 |
| 12-HEPE | 0.3095 | 1.6905 |
| 12-HETE | 0.2340 | 1.7660 |
| 12-HpETE screen | NA | NA |
| 13-HODE | 0.6133 | 1.3867 |
| 13-HOTE | 0.4615 | 1.5385 |
| 13-HpODE screen | NA | NA |
| 13-KODE | 0.4933 | 1.5067 |
| 14_15-DiHETE | 0.7328 | 1.2545 |
| 14_15-DiHETrE | 0.8823 | 1.1177 |
| 14(15)-EpETE | NA | NA |
| 14(15)-EpETrE | 0.8470 | 1.1801 |
| 14-HDoHE | 0.1819 | 1.8181 |
| 15_16-DiHODE | 0.6934 | 1.2774 |
| 15(16)-EpODE | 0.6750 | 1.2925 |
| 15-deoxy PGJ2 | NA | NA |
| 15-HEPE | 0.8853 | 1.1147 |
| 15-HETE | 0.7685 | 1.2315 |
| 15-HpETE screen | NA | NA |
| 15-KETE | NA | NA |
| 15-Keto PGE2 | 0.7578 | 1.2941 |
| 16(17)-EpDPE | NA | NA |
| 17_18-DiHETE | 0.8687 | 1.1251 |
| 17(18)-EpETE | NA | NA |
| 17-HDoHE | 0.7360 | 1.2640 |
| 19_20-DiHDoPE | 0.8441 | 1.1559 |
| 19(20)-EpDPE | 0.3310 | 1.5661 |
| 20-HETE | NA | NA |
| 4-HDoHE | 0.7518 | 1.2482 |
| 5_15-DiHETE | NA | NA |
| 5_6-DiHETrE | 0.9364 | 1.0636 |
| 5-HEPE | 0.7272 | 1.2865 |
| 5-HETE | 0.7180 | 1.2820 |
| 5-HpETE screen | NA | NA |
| 5-KETE | NA | NA |
| 6-keto PGF1a | 1.0762 | 0.9238 |
| 6-trans-LTB4 | NA | NA |
| 8_15-DiHETE | NA | NA |
| 8_9-DiHETrE | 0.9239 | 1.0761 |
| 8(9)-EpETrE | 0.4048 | 1.6249 |
| 8-HETE | 0.8075 | 1.1925 |
| 9_10-DiHHex | NA | NA |
| 9_10-DiHODE | 0.7973 | 1.1931 |
| 9_10-DiHOME | 0.7782 | 1.2218 |
| 9_10-e-DiHO | NA | NA |
| 9_10-EpO | 0.9150 | 1.0892 |
| 9(10)-EpODE | NA | NA |
| 9(10)-EpOME | 0.8180 | 1.1820 |
| 9_12_13-TriHOME | 0.8944 | 1.1056 |
| 9-HEPE | 0.8366 | 1.1715 |
| 9-HETE | 0.6077 | 1.3923 |
| 9-HODE | 0.6317 | 1.3683 |
| 9-HOTE | 0.4553 | 1.5447 |
| 9-HpODE screen | NA | NA |
| 9-KODE | 0.5286 | 1.4714 |
| 9-Nitrooleate | NA | NA |
| Lipoxin A4 | NA | NA |
| LTB4 | NA | NA |
| LTB5 | NA | NA |
| LTE4 | NA | NA |
| PGD2 | 0.9501 | 1.0551 |
| PGE1 | 0.5959 | 1.4041 |
| PGE2 | 0.8045 | 1.1955 |
| PGE3 | NA | NA |
| PGF2a | 0.9116 | 1.0842 |
| PGF3a | NA | NA |
| Resolvin D1 | NA | NA |
| TXB2 | 0.7728 | 1.2272 |
Factors:
| F1 | Treatment:no PH (no pulmonary hypertension) |
| F2 | Treatment:PH (pulmonary hypertension) |
